Ireland - English - HPRA (Health Products Regulatory Authority)

sol s.p.a. - nitric oxide - medicinal gas, compressed - 450 ppm mole(s) - other respiratory system products; nitric oxide

Canada - English - Health Canada

sandoz canada incorporated - ranitidine (ranitidine hydrochloride) - tablet - 150mg - ranitidine (ranitidine hydrochloride) 150mg - histamine h2-antagonists

Canada - English - Health Canada

pharmascience inc - ranitidine (ranitidine hydrochloride) - tablet - 150mg - ranitidine (ranitidine hydrochloride) 150mg - histamine h2-antagonists

Canada - English - Health Canada

dominion pharmacal - ranitidine (ranitidine hydrochloride) - tablet - 150mg - ranitidine (ranitidine hydrochloride) 150mg - histamine h2-antagonists

Canada - English - Health Canada

essential pharma switzerland gmbh - apraclonidine (apraclonidine hydrochloride) - solution - 1% - apraclonidine (apraclonidine hydrochloride) 1% - eent drugs, miscellaneous

Canada - English - Health Canada

essential pharma switzerland gmbh - apraclonidine (apraclonidine hydrochloride) - solution - 0.5% - apraclonidine (apraclonidine hydrochloride) 0.5% - eent drugs, miscellaneous

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - clonidine 2.52mg equivalent to 0.1 mg/24hr - transdermal patch - 0.1 mg/24h - active: clonidine 2.52mg equivalent to 0.1 mg/24hr excipient: adhesive 8400e/000 colloidal silicon dioxide durotak 87-613a ethylenevinylacetate copolymer heptane light liquid paraffin no tox ink brown- fgn4476 - clonidine transdermal system usp is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - clonidine 5.04mg equivalent to 0.2 mg/24hr - transdermal patch - 0.2 mg/24h - active: clonidine 5.04mg equivalent to 0.2 mg/24hr excipient: adhesive 8400e/000 colloidal silicon dioxide durotak 87-613a ethylenevinylacetate copolymer heptane light liquid paraffin no tox ink brown- fgn4476 - clonidine transdermal system usp is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - clonidine 7.56mg equivalent to 0.3mg/24hr - transdermal patch - 0.3 mg/24h - active: clonidine 7.56mg equivalent to 0.3mg/24hr excipient: adhesive 8400e/000 colloidal silicon dioxide durotak 87-613a ethylenevinylacetate copolymer heptane light liquid paraffin no tox ink brown- fgn4476 - clonidine transdermal system usp is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

Canada - English - Health Canada

teva canada limited - clonidine hydrochloride - tablet - 0.025mg - clonidine hydrochloride 0.025mg - central alpha-agonists